1. Home
  2. APLS vs RGTI Comparison

APLS vs RGTI Comparison

Compare APLS & RGTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
    SELLHOLDBUYas of 2 days ago
  • RGTI
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • APLS 2009
  • RGTI 2013
  • Country
  • APLS United States
  • RGTI United States
  • Employees
  • APLS N/A
  • RGTI N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • RGTI Retail: Computer Software & Peripheral Equipment
  • Sector
  • APLS Health Care
  • RGTI Technology
  • Exchange
  • APLS Nasdaq
  • RGTI Nasdaq
  • Market Cap
  • APLS 3.3B
  • RGTI 3.7B
  • IPO Year
  • APLS 2017
  • RGTI N/A
  • Fundamental
  • Price
  • APLS $24.27
  • RGTI $8.15
  • Analyst Decision
  • APLS Buy
  • RGTI Strong Buy
  • Analyst Count
  • APLS 18
  • RGTI 4
  • Target Price
  • APLS $45.53
  • RGTI $14.50
  • AVG Volume (30 Days)
  • APLS 1.8M
  • RGTI 59.6M
  • Earning Date
  • APLS 05-06-2025
  • RGTI 03-05-2025
  • Dividend Yield
  • APLS N/A
  • RGTI N/A
  • EPS Growth
  • APLS N/A
  • RGTI N/A
  • EPS
  • APLS N/A
  • RGTI N/A
  • Revenue
  • APLS $781,367,000.00
  • RGTI $10,790,000.00
  • Revenue This Year
  • APLS $12.95
  • RGTI $47.23
  • Revenue Next Year
  • APLS $21.35
  • RGTI $127.11
  • P/E Ratio
  • APLS N/A
  • RGTI N/A
  • Revenue Growth
  • APLS 97.02
  • RGTI N/A
  • 52 Week Low
  • APLS $23.25
  • RGTI $0.66
  • 52 Week High
  • APLS $59.91
  • RGTI $21.42
  • Technical
  • Relative Strength Index (RSI)
  • APLS 40.15
  • RGTI 41.50
  • Support Level
  • APLS $23.25
  • RGTI $8.45
  • Resistance Level
  • APLS $24.88
  • RGTI $10.31
  • Average True Range (ATR)
  • APLS 0.91
  • RGTI 0.99
  • MACD
  • APLS 0.11
  • RGTI -0.02
  • Stochastic Oscillator
  • APLS 38.35
  • RGTI 15.14

Stock Price Comparison Chart: APLS vs RGTI

APLS
RGTI
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100APLS VS RGTI

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About RGTI Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use